Federal health officials say that the manufacturer of a medical instrument at the center of a recent “superbug” outbreak in Los Angeles did not receive federal clearance to sell the device.
The Food and Drug Administration has confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical device sold in the U.S.
Despite the lack of clearance, the FDA said doctors should continue using the device because it’s not clear that a federal review would have prevented the recent infections.
Olympus has now submitted an application for the device that is currently under FDA review
Was this article valuable?
Here are more articles you may enjoy.
Seven People Charged in $100M Workers’ Compensation Fraud Operation in Florida
Medical Firm to Build $600M Pharmaceutical Manufacturing Site in North Carolina
Jury Finds No Gun Defect, Sides With Sig Sauer in Unintended Discharge Case
Should Parents Be Responsible for Kids Getting Hurt and Killed on E-Bikes? 

